# Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement

> **NCT01376011** · EARLY_PHASE1 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 106 (actual)

## Conditions studied

- Stroke
- Problem of Aging

## Interventions

- **DIETARY_SUPPLEMENT:** quercetin/placebo

## Key facts

- **NCT ID:** NCT01376011
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2012-06
- **Final completion:** 2014-12
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2015-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376011, "Modulation of Cerebral Blood Flow Using Quercetin, a Nutritional Supplement". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01376011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*